The effect of somatostatin analogs and acromegaly on the upper gastrointestinal system
ConclusionThe study showed that octreotide LAR treatment could be a risk factor in addition to known factors for the development of gastritis in patients with acromegaly.
Source: Pituitary - Category: Endocrinology Source Type: research
More News: Acromegaly | Endocrinology | Endoscopy | Gastric Ulcer | Gastritis | Gastroenterology | Study | Upper Endoscopy